Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$40.97 - $43.33 $4.66 Million - $4.92 Million
-113,645 Reduced 67.73%
54,137 $2.29 Million
Q4 2023

Feb 14, 2024

BUY
$32.77 - $42.31 $2.1 Million - $2.71 Million
64,038 Added 61.73%
167,782 $7.01 Million
Q2 2023

Aug 14, 2023

SELL
$24.24 - $40.97 $52,600 - $88,904
-2,170 Reduced 2.05%
103,744 $3.94 Million
Q4 2022

Feb 10, 2023

SELL
$27.6 - $32.99 $1.92 Million - $2.3 Million
-69,606 Reduced 39.66%
105,914 $3.08 Million
Q3 2022

Nov 14, 2022

BUY
$28.74 - $39.9 $57,480 - $79,800
2,000 Added 1.15%
175,520 $5.26 Million
Q2 2022

Aug 15, 2022

BUY
$35.0 - $43.59 $378,595 - $471,513
10,817 Added 6.65%
173,520 $6.27 Million
Q1 2022

May 12, 2022

BUY
$43.12 - $50.3 $150,920 - $176,050
3,500 Added 2.2%
162,703 $7.04 Million
Q4 2021

Feb 14, 2022

BUY
$47.6 - $65.0 $2.82 Million - $3.85 Million
59,203 Added 59.2%
159,203 $7.98 Million
Q2 2021

Aug 13, 2021

BUY
$70.26 - $76.64 $7.03 Million - $7.66 Million
100,000 New
100,000 $7.2 Million

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Murchinson Ltd. Portfolio

Follow Murchinson Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Murchinson Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Murchinson Ltd. with notifications on news.